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Lymphovascular invasion (LVI) refers to the presence of 
tumor cells within vascular spaces (i.e., lymphatics or small 
capillaries) surrounding tumors. The finding of LVI is associ­
ated with a higher risk of lymph node metastases and is a poor 
prognostic factor in women without lymph node metastases 
[1]. For example, among patients with T1N0M0 breast cancer, 
there is an increased frequency of recurrence and death due to 
breast carcinoma with LVI [2]. The proper determination of 
the presence or absence of LVI may have clinical significance 
in medical decision making as well. The accurate determina­
tion of the presence or absence of LVI is a factor in determin­
ing risk of having a positive sentinel node [3], or having addi­
tional positive axillary nodes after a positive sentinel node 
biopsy [4] in women with early­stage breast cancer. The deter­
mination of nodal risk influences the decision of the treating 
physicians as to whether a sentinel node biopsy or completion 
axillary dissection is necessary.
Recognition of lymphatic tumor emboli on microscopic 
section is dependent on the pathologist. There is a potential 
for significant inter­observer variation in the diagnosis of LVI 
amongst pathologists. For instance, Gilchrist et al. [5] noted 
that when three surgical pathologists were told to assess for 
LVI in a pT1­2 N0 M0 histological mastectomy case, all three 
concurred in only 12 of 35 cases. One source of inter­observer 
variation is retraction artifact during histological processing 
that mimics true LVI. Though retraction artifact was previous­
ly considered an insignificant finding that interfered with the 
ability to make an appropriate diagnosis [6], more recent stud­
ies have suggested it is not a random phenomenon from tissue 
fixation. Instead, it may be a result of tumor­stromal interac­
tions suggesting a poor prognosis [7,8]. The purposes of this 
article are to provide an illustrative description comparing 
true LVI to retraction artifact and provide insight of quantify­
ing the significance of retraction artifact in future studies.
In breast stroma, cancer cells form in clusters near lymphat­
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On a pathological specimen of breast cancer cells, retraction 
artifact during histological processing mimics true lymphovascular 
invasion (LVI). The accurate determination of the presence or 
absence of LVI is a factor in determining risk of having a positive 
sentinel node, or having additional positive axillary nodes after a 
positive sentinel node biopsy in women with early-stage breast 
cancer. The determination of nodal risk influences the decision 
of the treating physicians as to whether a sentinel node biopsy 
or completion axillary dissection is necessary. On slide prepara-
tion, ideal factors favoring true LVI include: a definite endothelial 
lining, with endothelial nuclei that seem to protrude into the 
lymphatic space; invasion in one lymphatic vessel (LV) lumen 
with nearby cancer glands that have minimal or no retraction; a 
tumor embolus in a LV clear lumen with outside nearby tumor 
bulk; a tumor embolus that is different in shape than its surround-
ing clear LV space; and a positive stain for fibrin, CD31, or CD34 
on tumor embolus periphery.
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ic vessels and as glands (Figure 1). The term “lymphatic vessel” 
refers to a lymph vessel or capillary; these vessels are endothelial­
lined channels, devoid of red blood cells, and lacking a smooth 
muscle cell wall [2]. In true LVI, cancer cells break through 
the basement membrane. The lumenal invasion is a transient 
event; thus, it is rarely captured on histologic specimen. A 
tumor embolus forms in the lumen. On slide preparation, 
ideal factors favoring true LVI include: 1) a definite endotheli­
al lining, with endothelial nuclei that seem to protrude into 
the lymphatic space; 2) invasion in one lymphatic vessel (LV) 
lumen with nearby cancer glands that have minimal or no 
retraction; 3) a tumor embolus in a LV clear lumen with out­
side nearby tumor bulk; 4) a tumor embolus that is different in 
shape than its surrounding clear LV space; and 5) a positive 
stain for fibrin, CD31, or CD34 on tumor embolus periphery 
[9,10].
Figure 2A is an illustration of the ideal characteristics favor­
ing true LVI. Figure 2B shows pathological specimens of true 
LVI stained with hematoxylin and eosin (H&E, at ×40 magni­
fication), and with CD31 or CD34 (both at ×20 magnifica­Figure 1. In breast stroma, cancer cells form in clusters near lymphatic 
vessels and as glands. 
Lymphatic vessel
lumen
Gland
Breast stroma Cluster
Figure 2. True lymphovascular invasion (LVI) as (A) an illustration, and (B) on histological specimen with hematoxylin and eosin (H&E stain,×20), CD31, 
and CD34 staining (both at ×40 magnification, with detail emphasizing the lymphatic space involved).
Stain
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A B
Figure 3. Retraction artifact mimicking lymphovascular invasion as (A) an illustration, and (B) on histological specimen of three separate samples (H&E 
stain,×20).
Artifact: H&E Artifact #1 Artifact #3 Artifact #2
A B
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tion, with detail emphasizing the lymphatic space involved). 
The involved lymphatic space is often in immediate proximity 
of an artery and a nerve trunk, histologic features very helpful 
in identifying LVI with certainty, but depending on the plane 
of section not all three elements are always present on the slide. 
For example Figure 2 illustrates LVI and an adjacent artery, 
but no nerve trunk is present in the plane of section. Figure 3A 
is an illustration of the ideal characteristics that favor retrac­
tion artifact. Figure 3B shows three cases of pathological spec­
imens of retraction artifact stained with H&E.
A variable degree of retraction artifact may be seen in 16% 
to 60% of invasive breast carcinomas [8,11]. Acs et al. [11] 
found that extensive retraction artifact stained with D2­40, 
especially in pT1 and pT2 breast carcinomas, correlates with 
tumor size, histologic type, histologic grade, presence of lym­
phatic spread, and poor outcome. Irie et al. [8] observed that 
retraction artifact was seen in 84% of cases of infiltrating duc­
tal carcinoma and similarly suggested that retraction might 
represent true prelymphatic space involvement. Though the 
findings are interesting, they are limited. For example, in the 
Acs et al. [11] study, D2­40 may not have been an ideal mark­
er for finding LVI, as D2­40 staining of myoepithelial cells and 
myofibroblasts at the edge of retraction spaces of ductal carci­
noma in situ may be misinterpreted as tumor LVI [12], and 
the direct destruction of the endothelial cell layer by enzymatic 
digestion of matrix proteins by the neoplastic cells can result 
in lack of expression of D2­40 [8]. In the Irie et al. [8] study, 
retraction of >25% of the specimen was seen in 168 of 199 
infiltrating ductal carcinoma specimens, but only 1 of 188 
ductal carcinoma in situ specimens. 
Thus, it is unclear how retraction artifact should be considered 
in cancer staging (e.g., T or N stage). Multiple stains (e.g., with 
type IV collagen, cytokeratin, and smooth muscle actin) have 
been recommended in LVI diagnosis [13,14]. A combination 
scoring system will likely be necessary in future studies of both 
LVI and retraction artifact to more clearly prognosticate the 
incidence of tumor metastasis. To further the assess the signifi­
cance of retraction artifact, we recommend: 1) quantifying 
the instances of retraction artifact in one specimen; 2) noting 
tumor histology; 3) using more than one cellular marker in 
preparation; and 4) grading the size of the largest glands un­
dergoing LVI, as these may be associated with a stronger force 
of tumor­stromal interaction.
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